Section Arrow
EMBC.NASDAQ
- Embecta Corp
Quotes are at least 15-min delayed:2025/11/15 01:11 EST
Regular Hours
Last
 14.55
+0.14 (+0.97%)
Day High 
14.59 
Prev. Close
14.41 
1-M High
14.91 
Volume 
299.48K 
Bid
13
Ask
15
Day Low
14.07 
Open
14.3 
1-M Low
13.03 
Market Cap 
842.77M 
Currency USD 
P/E 10.15 
%Yield 4.12 
10-SMA 13.82 
20-SMA 13.91 
50-SMA 14.18 
52-W High 21.48 
52-W Low 9.2 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.42/--
Enterprise Value
2.44B
Balance Sheet
Book Value Per Share
-11.45
Cash Flow
Cash Flow Yield
0.16
Income Statement
Total Revenue
1.12B
Operating Revenue Per Share
19.04
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MLSSMilestone Scientific0.33-0.0497-13.09%-- 
AVTRAvantor11.38-0.32-2.74%11.55PE
BAXBaxter International18.47-0.23-1.23%140.32PE
HOLXHologic74.15-0.11-0.15%30.81PE
XRAYDENTSPLY SIRONA10.52-0.43-3.93%-- 
Quotes are at least 15-min delayed:2025/11/15 01:11 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safetydevices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.